This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain

NCT03285373 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1008

Last updated 2020-02-18

Study results available
· View outcomes & findings →

Summary

The primary objective of the study is to describe the usage of NOACs in patients with NVAF, in the hospital setting, based on the baseline characteristics at the time of first NOAC initiation.

Conditions

Interventions

DRUG

NOAC

New Oral Anticoagulant

Sponsors & Collaborators

Principal Investigators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-29
Primary Completion
2019-01-31
Completion
2019-01-31
FDA Drug
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03285373 on ClinicalTrials.gov